Comparison of cardiac troponin T and troponin I assays - Implications of analytical and biochemical differences on clinical performance

Clinical Laboratory

Volumn 50, Issue 9-10, 2004, Pages 521-528

  Giannitsis, Evangelos ^a   Katus, Hugo A ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b NONE

Author keywords

Acute coronary syndromes; Renal disease; Standardization; Troponin I; Troponin T

Indexed keywords

TROPONIN I; TROPONIN T;

ANALYTIC METHOD; CONCENTRATION (PARAMETERS); DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; PROGNOSIS; REVIEW; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION;

ACUTE DISEASE; CHEMISTRY, CLINICAL; CORONARY DISEASE; HUMANS; MYOCYTES, CARDIAC; PROGNOSIS; TROPONIN I; TROPONIN T;

EID: 4744357378     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Katus HA, Remppis A, Neumann FJ, et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation 1991;83:902-912.
2. Ohman EM, Topol EJ, Califf RM, et al for the GUSTO-IIa investigators. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996; 335: 1333-41.
3. Hamm, CW, Goldmann B, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997; 337: 1648-53.
4. Myocardial infarction redefined: a Consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969.
5. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 2002; 106: 1893-900.
6. Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Eur Heart J 2002; 23: 1809-40.
7. Dean KJ. Biochemistry and molecular biology of troponin I and T. In: Wu AHB, ed. Cardiac markers. Totowa, NJ: Humana, 1998: 193-204.
8. Katus HA, Remppis A, Scheffold T, et al. Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and non-reperfused myocardial infarction. Am J Cardiol 1991; 67: 1360-1367.
9. Remppis A, Scheffold T, Greten J, et al. Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol 1995; 27: 793-803.
10. Jaffe AS, Ravkilde J, Roberts R, Naslund U, Apple FS, Galvani M, Katus H. It's time for a change to a troponin standard. Circulation 2000; 102: 1216-20.
11. Wu AH, Feng YJ, Moore R, et al. Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I: American Association for Clinical Chemistry Subcommittee on c TnI Standardization. Clin Chem 1998; 44: 1198-1208.
12. Adams JE, Bodor GS, Davila-Roman VG, et al. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation 1993; 88: 101-6.
13. Müller Bardorff M, Hallermeyer K, Schröder AA, et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem 1997; 43: 458-66.
14. Haller C, Zehelein J, Remppis A, et al. Cardiac troponin T in patients with end-stage renal disease: absence of expression in truncal skeletal muscle. Clin Chem 1998; 44: 930-8.
15. Christenson RH, Duh SH, Apple FS, et al. Standardization of cardiac troponin I assays: round Robin of ten candidate reference materials. Clin Chem 2001; 47: 431-7.
16. Labugger R, Organ L, Collier C, Atar D, Van Eyk JE. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 2000; 102: 1221-6.
17. Katrukha A, Bereznikova A, Filatov V, Esakova T. Biochemical factors influencing measurement of cardiac troponin I in serum. Clin Chem Lab Med 1999; 37: 1091-5.
18. Stiegler H, Fischer Y, Vazquez-Jimenez JF, Graf J, Filzmaier K, Fausten B, Janssens U, Gressner AM, Kunz D. Lower cardiac troponin T and I results in heparin-plasma than in serum. Clin Chem. 2000; 46: 1338-44.
19. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001; 344:1879-87.
20. FRISC II-Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. Lancet 1999; 354: 708-15.
21. Antman EM, Braunwald E, Wybenga D, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342-49.
22. Collinson PO, Jorgensen B, Sylven C, et al. Recalibration of the point-of-care test for CARDIAC T Quantitative with Elecsys Troponin T 3rd generation. Clin Chim Acta 2001; 307: 197-203.
23. Lindahl B, Venge P, Wallentin L, for the FRISC Study Group. Relation between cardiac troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996; 93: 1651-57.
24. Lenderink T, Boersma E, Heeschen C, et al for the CAPTURE Investigators. Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA. Eur Heart J. 2003; 24: 77-85.
25. Giannitsis E, Bardorff MM, Schweikart S, et al. Relationship of cardiac troponin T and procoagulant activity in unstable angina. Thromb Haemost 2000; 83: 224-8.
26. Heeschen C, van Den Brand MJ, Hamm CW, Simoons ML. Angiographic findings in patients with refractory unstable angina according to troponin T status. Circulation 1999;100:1509-14.
27. Frey N, Dietz A, Kurowski V, et al. Angiographic correlates of a positive troponin T test in patients with unstable angina. Crit Care Med 2001; 29: 1130.
28. Ottani F, Galvani M, Ferrini D, et al. Direct comparison of early elevations of cardiac troponin T and I in patients with clinical unstable angina. Am Heart J 1999;137:284-291
29. Olatidoye AG, Wu AH, Feng YJ, Waters D. Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies. Am J Cardiol 1998; 81: 1405-10.
30. Christenson RH, Duh SH, Newby LK, et al. Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators. Clin Chem 1998; 44: 494-501.
31. Heeschen C, Deu A, Langenbrink L, et al. Analytical and diagnostic performance of troponin assays in patients suspicious for acute coronary syndromes. Clin Biochem 2000; 33: 359-68.
32. Luscher MS, Thygesen K, Ravkilde J, Heickendorff L. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. TRIM Study Group. Thrombin Inhibition in Myocardial ischemia. Circulation 1997 21;96:2578-85.
33. Lindahl B, Venge P, Wallentin L. Comparison of troponin T and I for prediction of mortality in unstable coronary artery disease. Eur Heart Journal 1997; 18: 123.
34. Heeschen C, Hamm CW, Goldmann B, et al, for the PRISM Study Investigators. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. LANCET 1999; 354: 1757-62.
35. Morrow DA, Rifai N, Tanasijevic MJ, et al. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a thrombolysis in myocardial infarction (TIMI) IIB substudy. Clin Chem 2000; 46: 453-460.
36. Collinson PO, Boa FG, Gaze DC. Measurement of cardiac troponins. Ann Clin Biochem 2001; 38: 423-449.
37. Newby LK, Ohman EM, Christenson RH, et al. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B tro-ponin T substudy. Circulation 2001; 103: 2891-6.
38. Hamm CW, Heeschen C, Goldmann B, et al, for the CAPTURE Study Investigators. Benefit of abciximab in patients with refractrory unstable angina in relation to serum troponin levels. N Engl J Med 1999; 340: 1623-9.
39. Zimmermann R, Baki S, Dengler TJ, et al. Troponin T release after heart transplantation. Br Heart J 1993; 69: 395-8.
40. Giannitsis E, Muller-Bardorff M, Kurowski V, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000; 102: 211-7.
41. Dierkes J, Domrose U, Westphal S, et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000; 102: 1964-9.
42. Meyer T, Binder L, Hruska N, et al. Cardiac troponin I elevation in acute pulmonary embolism is associated with right ventricular dysfunction. J Am Coll Cardiol 2000; 36: 1632-6.
43. Konstantinides S, Geibel A, Olschewski M, et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 2002; 106: 1263-8.
44. Aviles RJ, Askari AT, Lindahl B, et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 2002; 346: 2047-52.
45. Hamm CW, Giannitsis E, Katus HA. Cardiac troponin elevations in patients without acute coronary syndrome. Circulation 2002;106: 2871-2.
46. Fredericks S, Murray JF, Bewick M, et al. Cardiac troponin T and creatine kinase MB are not increased in exterior oblique muscle of patients with renal failure. Clin Chem 2001; 47: 1023-1030.
47. Bhayana V, Gougoulias T, Cohee S. Discordance between results for serum troponin T and I in renal disease. Clin Chem 1995; 41: 312-317.
48. Katus HA, Haller C, Muller-Bardorff M, et al. Cardiac troponin T in end-stage renal disease patients undergoing chronic maintenance hemodialysis. Clin Chem 1995; 41: 1201-3.
49. Ishii J, Nomura M, Okuma T, et al. Risk stratification using serum concentrations of cardiac troponin T in patients with end-stage renal disease on chronic maintenance dialysis. Clin Chim Acta 2001; 312: 69-79.
50. Ooi DS, Zimmerman D, Graham J, Wells GA. Cardiac troponin T predicts long-term outcomes in hemodialysis patients. Clin Chem 2001;47: 412-7.
51. Porter GA, Norton T, Bennett WB. Troponin T, a predictor of death in chronic haemodialysis patients. Eur Heart J 1998; 19: N34-N37.
52. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002; 106: 2941-5.
53. Herzog CA, Ma JZ, Collins AJ. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. N Engl J Med 1998 ;339: 799-805.
54. Apple FS, Wu AHB, Jaffe AS. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 2002; 144: 981-6.
55. Panteghini M, Pagani F, Yeo KTJ, Apple F, Christenson RH, Dati F, Mair F, Ravkilde J, Wu AHB. Evaluation of imprecision for cardiac troponin assay at low-range concentrations. Clin Chem 2004; 50: 2 e-pub